| 1st Dec 2022 7:00 am |
RNS |
Faron Appoints Maija Hollmén PhD as CSO |
| 18th Nov 2022 4:30 pm |
RNS |
Amendment Terms and Conditions with IPF Partners |
| 2nd Nov 2022 7:00 am |
RNS |
Faron Announces Poster Presentation at SITC |
| 31st Oct 2022 7:00 am |
RNS |
BEXMAB Study Update |
| 19th Oct 2022 9:20 am |
RNS |
Holding(s) in Company |
| 18th Oct 2022 12:30 pm |
RNS |
Holding(s) in Company |
| 18th Oct 2022 7:00 am |
RNS |
Faron Announces Melanoma Cohort Data from MATINS |
| 14th Oct 2022 7:00 am |
RNS |
Results of Placing |
| 13th Oct 2022 5:31 pm |
RNS |
Proposed Issue and Placing of Shares |
| 22nd Sep 2022 7:00 am |
RNS |
Grant of Options |
| 20th Sep 2022 7:00 am |
RNS |
Top-Line Data on Bexmarilimab Dose Variation |
| 14th Sep 2022 7:00 am |
RNS |
Faron to Host Bexmarilimab Update Webcast |
| 13th Sep 2022 7:00 am |
RNS |
Traumakine Data Presented at MHSR Symposium |
| 7th Sep 2022 1:00 pm |
RNS |
Faron to Present at Upcoming Conferences |
| 25th Aug 2022 7:00 am |
RNS |
Faron Reports 2022 Half-Year Financial Results |
| 8th Aug 2022 7:00 am |
RNS |
Notice of Half-Year Financial Results |
| 7th Jul 2022 9:45 am |
RNS |
Results of EGM |
| 30th Jun 2022 5:00 pm |
RNS |
Holding(s) in Company |
| 28th Jun 2022 1:47 pm |
RNS |
Registration of New Shares |
| 28th Jun 2022 7:00 am |
RNS |
Announcement of Placing |
| 16th Jun 2022 12:00 pm |
RNS |
Faron notice of EGM |
| 15th Jun 2022 7:00 am |
RNS |
Faron Announces Top-Line 12-Month Survival Results |
| 8th Jun 2022 7:00 am |
RNS |
First Patient Dosed in Ph I/II BEXMAB Combo Study |
| 1st Jun 2022 7:00 am |
RNS |
Exercise of options |
| 30th May 2022 7:00 am |
RNS |
Presentation of Biomarker Analysis at ASCO |
| 16th May 2022 7:00 am |
RNS |
FDA and FIMEA approve BEXMAB study to begin |
| 12th May 2022 3:50 pm |
RNS |
Ex Vivo Data Presented at EHA2022 Congress |
| 9th May 2022 7:00 am |
RNS |
Mol Cancer Ther Publishes Bexmarilimab Research |
| 4th May 2022 11:15 am |
RNS |
Grant of options |
| 22nd Apr 2022 1:01 pm |
RNS |
Board Changes |
| 22nd Apr 2022 1:00 pm |
RNS |
Results of AGM |
| 21st Apr 2022 4:30 pm |
RNS |
Faron Presents Melanoma Data at EADO |
| 8th Apr 2022 3:45 pm |
RNS |
Managers’ Transactions |
| 5th Apr 2022 7:00 am |
RNS |
Faron Closes HIBISCUS Trial |
| 25th Mar 2022 9:00 am |
RNS |
Notice of Faron Pharmaceuticals Ltd’s AGM |
| 25th Mar 2022 7:15 am |
RNS |
Faron´s Annual Report 2021 Published |
| 25th Mar 2022 7:00 am |
RNS |
Financial Statement January 1 to December 31 2021 |
| 14th Mar 2022 7:00 am |
RNS |
Faron Publishes Research From INTEREST Trial |
| 9th Mar 2022 7:00 am |
RNS |
Presentation of Biomarker Data at AACR 2022 |
| 7th Mar 2022 7:00 am |
RNS |
Notice of 2021 Full-Year Results and Annual Report |
